Doliente, Luzviminda B.
HRN: 00-57-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2024
CIPROFLOXACIN 500MG (TAB)
08/24/2024
08/31/2024
PO
500mg
BID
Complicated Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes